ArticleThe Kaohsiung journal of medical sciences2019

miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.

Yi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.